Ocrevus subkutan 920 mg/23 ml

Ocrevus subkutan 920 mg/23 ml is a medicine authorised by Swissmedic under authorisation number 68988. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 November 2024 and the authorisation is limited until 14 November 2029. ATC code L04AG08 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 68988
  • ATC L04AG08
  • Biotechnological medicines
Authorisation data
Authorisation number68988
NameOcrevus subkutan 920 mg/23 ml
Full nameOcrevus subkutan 920 mg/23 ml, Injektionslösung
Authorisation holderRoche Pharma (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AG08
First authorisation15 November 2024
Authorisation validity14 November 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Ocrevus subkutan 920 mg/23 ml, InjektionslösungA15 November 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AG0801.99.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ocrevus subkutan 920 mg/23 ml authorised in Switzerland?

Yes. Ocrevus subkutan 920 mg/23 ml is authorised by Swissmedic under authorisation number 68988, data as of 01 September 2026. The authorisation is limited until 14 November 2029.

Which dispensing category does Ocrevus subkutan 920 mg/23 ml have?

Ocrevus subkutan 920 mg/23 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ocrevus subkutan 920 mg/23 ml?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com